BioQuest Corp. (BQST)
USD 1.0
(0.0%)
USD 1.0
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | 467.57 | 1408.00 | 164.00 | - |
| Gross Profit | - | - | -467.57 | -1408.00 | -164.00 | - |
| Operating Expenses | 89.76 | 49.06 Thousand | 817.92 Thousand | 2.2 Million | 356.55 Thousand | 2175.00 |
| Selling, General and Administrative Expenses | 89.76 | 49.06 Thousand | 817.92 Thousand | 2.2 Million | 356.55 Thousand | 2175.00 |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | 206.7 Thousand | 530 Thousand | - | - |
| Cost and Expenses | 89.76 | 49.06 Thousand | 817.92 Thousand | 2.2 Million | 356.55 Thousand | 2175.00 |
| Operating Income | -89.76 | -49.06 Thousand | -817.92 Thousand | -2.2 Million | -356.55 Thousand | -2180.00 |
| Interest Expense | 33.57 Thousand | 41.6 Thousand | 78.61 Thousand | 37.63 Thousand | 2475.00 | - |
| Income Tax Expense | -89.76 | -167.89 Thousand | -99.61 Thousand | 37.63 Thousand | 2475.00 | -2.18 |
| Earnings before Tax | -123.32 Thousand | -140.66 Thousand | -821.02 Thousand | -2.32 Million | -359.02 Thousand | -2175.00 |
| Net Income | -123.33 | -140.66 Thousand | -721.4 Thousand | -2.36 Million | -361.5 Thousand | -2175.00 |
| Earnings Per Share Basic | - | -0.01 | -0.07 | -0.29 | -0.09 | -0.02 |
| Earnings Per Share Diluted | - | -0.01 | -0.07 | -0.29 | -0.09 | -0.02 |
| Weighted Average Shares Outstanding | 11.48 Million | 11.44 Million | 10.13 Million | 8.28 Million | 4.1 Million | 102.12 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 11.48 Million | 11.44 Million | 10.13 Million | 8.28 Million | 4.1 Million | 102.12 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -33.57 | -49.06 Thousand | -742.4 Thousand | -2.28 Million | -356.55 Thousand | -2175.00 |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 89.75 Thousand | 74.23 Thousand | 6503.00 | 2214.00 | 6763.00 | 49.06 Thousand |
| Selling, General and Administrative Expenses | - | 74.23 Thousand | 6503.00 | 2214.00 | 6763.00 | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 89.75 Thousand | 74.23 Thousand | 6503.00 | 2214.00 | 6763.00 | 49.06 Thousand |
| Operating Income | -89.76 Thousand | -74.23 Thousand | -6500.00 | -2210.00 | -6760.00 | -49.06 Thousand |
| Interest Expense | 33.57 Thousand | 10.58 Thousand | 7700.00 | 7646.00 | 7646.00 | 41.6 Thousand |
| Income Tax Expense | -89.76 | -74.23 Thousand | -6503.00 | - | -43.27 Thousand | -167.89 Thousand |
| Earnings before Tax | -123.32 Thousand | -84.81 Thousand | -14.2 Thousand | -9860.00 | -14.4 Thousand | -140.66 Thousand |
| Net Income | -123.32 Thousand | -84.81 Thousand | -14.2 Thousand | -9860.00 | -14.4 Thousand | -140.66 Thousand |
| Earnings Per Share Basic | - | -0.01 | -0.00 | -0.00 | -0.00 | - |
| Earnings Per Share Diluted | - | -0.01 | -0.00 | -0.00 | -0.00 | - |
| Weighted Average Shares Outstanding | 11.48 Million | 11.48 Million | 11.48 Million | 11.48 Million | 11.48 Million | 11.44 Million |
| Weighted Average Shares Outstanding (Diluted) | 11.48 Million | 11.48 Million | 11.48 Million | 11.48 Million | 11.48 Million | 11.44 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | - | -74.23 Thousand | -6500.00 | -2210.00 | -6760.00 | - |
| Earnings Before Tax Margin | - | - | - | - | - | - |
688606
BAF
688050
000547
EXXRF
MVI